Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review.

Onoyama, Takumi

Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review. [electronic resource] - World journal of gastroenterology Jan 2020 - 353-365 p. digital

Publication Type: Journal Article; Systematic Review

2219-2840

10.3748/wjg.v26.i3.353 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized--adverse effects
Antineoplastic Agents, Immunological--adverse effects
Carcinoma, Non-Small-Cell Lung--chemically induced
Chemical and Drug Induced Liver Injury--etiology
Cholangitis, Sclerosing--chemically induced
Female
Humans
Lung Neoplasms--chemically induced
Male
Middle Aged
Nivolumab--adverse effects
Programmed Cell Death 1 Receptor--antagonists & inhibitors